Mylan To Generate 500 New Jobs In Ireland
Last week US generics company, Mylan, announced that they will be investing €76 million into expanding their operations in Ireland, in a move that will create 500 new pharmaceutical jobs.
By 2016, Mylan expect to have generated roughly 220 jobs in Galway, while 280 will be created at the company’s facilities in Dublin. The business currently employs around 700 people across Ireland.
With support from the government-funded Irish Development Authority (IDA), Mylan Pharmaceuticals will grow their R&D capabilities in Ireland, as well their manufacturing capabilities in their respiratory, injectables and oral solids franchises over the next five years.
The announcement came two months after the Irish government launched its Action Plan for Jobs, a strategy aimed at reconstructing Ireland’s economy and creating over 100,000 new jobs by 2016.
Richard Bruton, the country’s minister for jobs, enterprise and innovation, praised Mylan’s investment and commented that growing Ireland’s life sciences industry was a significant part of the government’s plan.
He noted that “employing approximately 50,000 people here directly, the sector is a major strength in Ireland, but we must build on this.”
The “announcement that Mylan, already a very important part of this sector, is expanding with the creation of over 500 jobs is a massive boost for the country,” he added.
Mylan’s CEO, Heather Bresch, spoke of the company’s commitment to the country, which has been one of the main European casualties of the economic downturn.
She commented that “Ireland … has proven to be a valuable location for Mylan, providing the company with access to a skilled and highly educated workforce that shares our strong work ethic and commitment to excellence.”
Other pharmaceutical companies to invest in Ireland as part of the scheme include Eli Lilly, which announced that they would invest €330 million into expanding their commercialisation and manufacturing facilities in Cork.